| Rivaroxaban 10 mg tablet |
| Company |
Formulation ID |
FDA Description |
|
Cardinal Health
|
F19278
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Cellulose, microcrystalline; Hypromelloses |
|
Janssen Pharmaceutical
|
F19279
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Hypromellose, unspecified; Microcrystalline cellulose |
| ------------------------------------------------------------------------------------ |
|
|
|
| Rivaroxaban 15 mg tablet |
| Company |
Formulation ID |
FDA Description |
|
Avera McKennan Hospital; Cardinal Health
|
F19280
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Cellulose, microcrystalline; Hypromelloses |
|
Janssen Pharmaceutical
|
F19281
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Hypromellose, unspecified; Microcrystalline cellulose |
| ------------------------------------------------------------------------------------ |
|
|
|
| Rivaroxaban 20 mg tablet |
| Company |
Formulation ID |
FDA Description |
|
Cardinal Health
|
F19282
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Cellulose, microcrystalline; Hypromelloses |
|
Janssen Pharmaceutical
|
F19283
|
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Hypromellose, unspecified; Microcrystalline cellulose |
| ------------------------------------------------------------------------------------ |
|
|
|